- Home
- BKU vs AMLX Comparison
BKU vs AMLX Comparison
Compare BKU & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKU | AMLX |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.8B |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BKU | AMLX |
|---|---|---|
| Price | $43.04 | $28.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $46.82 | $43.00 |
| AVG Volume (30 Days) | 870.5K | ★ 1.2M |
| Earning Date | 10-21-2026 | 11-13-2026 |
| Dividend Yield | ★ 3.04% | N/A |
| EPS Growth | 14.61 | ★ 65.46 |
| EPS | ★ 1.79 | N/A |
| Revenue | $21,732,000.00 | ★ $380,786,000.00 |
| Revenue This Year | $3.98 | N/A |
| Revenue Next Year | $4.93 | N/A |
| P/E Ratio | $24.18 | ★ N/A |
| Revenue Growth | 7.45 | ★ 1612.94 |
| 52 Week Low | $38.01 | $10.83 |
| 52 Week High | $52.11 | $41.14 |
Technical Indicators
Market Signals| Indicator | BKU | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 52.82 |
| Support Level | $41.36 | $26.12 |
| Resistance Level | $43.63 | $30.00 |
| Average True Range (ATR) | 1.02 | 1.27 |
| MACD | 0.22 | 0.25 |
| Stochastic Oscillator | 66.37 | 75.13 |
Price Performance
Historical ComparisonAbout BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses. The company also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products including commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.